Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancersBaris Sergi, Neslihan Yuksel-Catal, Selahattin Can Özcan et al.|Cell Death and Disease|2025Cited by 3